ILL
Company Details
Linkedin ID:
ipca
Website:
Employees number:
13,559
Number of followers:
401,372
NAICS:
3254
Industry Type:
Homepage:
ipca.com
IP Addresses:
0
Company ID:
IPC_3109701
Scan Status:
In-progress
Ipca Laboratories Limited Company CyberSecurity Posture
ipca.com
A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA
Ipca Laboratories Limited A.I CyberSecurity Scoring
ILL Risk Score (AI oriented)Between 750 and 799
ILL
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
ILL Global Score (TPRM)XXXX
ILL
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
ILL Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
ILL Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for ILL
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for Ipca Laboratories Limited in 2026.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Ipca Laboratories Limited in 2026.
Incident Types ILL vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Ipca Laboratories Limited in 2026.
Incident History — ILL (X = Date, Y = Severity)
ILL cyber incidents detection timeline including parent company and subsidiaries
ILL Company Subsidiaries
A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA
Loading...
ILL Similar Companies
SUN PHARMA
Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread acro
Astellas Pharma
Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneer
Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage
Zoetis
The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio an
Fresenius Kabi
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portf
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine
Catalent
Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier li
PT Kalbe Farma, Tbk
Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching t
Merck Group
This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trad
.png)
ILL CyberSecurity News
July 12, 2023 07:00 AM
Cyber-Biosecurity: How Can India’s Biomedical Institutions Develop Cyber Hygiene?
Last year, cyber attacks exposed the increasing vulnerability of India's biomedical institutions. This article serves as a primer for how...
October 17, 2022 07:00 AM
After Ipca Laboratories, pharma major Aarti Drugs hit by ransomware attack; data leaked on dark web
Leaked data (Aarti Drugs: 6 GB; Ipca Laboratories: 140 GB) includes employee records, formulation and research data, and financial and audit...
September 14, 2022 07:00 AM
Extortion group claims cyberattack on pharmaceutical giant IPCA Laboratories
IPCA Laboratories, one of the biggest pharmaceutical companies in India, has been hit by a cybercrime and extortion group that claims to have stolen 500...
February 13, 2022 04:59 AM
IPCA Laboratories increases stake in Trophic Wellness to 52.35%
IPCA Laboratories has acquired further 13.09% of the paid-up equity share capital of M/s. Trophic Wellness Private Ltd. (TWPL).
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
ILL CyberSecurity History Information
Official Website of Ipca Laboratories Limited
The official website of Ipca Laboratories Limited is https://www.ipca.com/.
Ipca Laboratories Limited’s AI-Generated Cybersecurity Score
According to Rankiteo, Ipca Laboratories Limited’s AI-generated cybersecurity score is 768, reflecting their Fair security posture.
How many security badges does Ipca Laboratories Limited’ have ?
According to Rankiteo, Ipca Laboratories Limited currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Has Ipca Laboratories Limited been affected by any supply chain cyber incidents ?
According to Rankiteo, Ipca Laboratories Limited has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.
Does Ipca Laboratories Limited have SOC 2 Type 1 certification ?
According to Rankiteo, Ipca Laboratories Limited is not certified under SOC 2 Type 1.
Does Ipca Laboratories Limited have SOC 2 Type 2 certification ?
According to Rankiteo, Ipca Laboratories Limited does not hold a SOC 2 Type 2 certification.
Does Ipca Laboratories Limited comply with GDPR ?
According to Rankiteo, Ipca Laboratories Limited is not listed as GDPR compliant.
Does Ipca Laboratories Limited have PCI DSS certification ?
According to Rankiteo, Ipca Laboratories Limited does not currently maintain PCI DSS compliance.
Does Ipca Laboratories Limited comply with HIPAA ?
According to Rankiteo, Ipca Laboratories Limited is not compliant with HIPAA regulations.
Does Ipca Laboratories Limited have ISO 27001 certification ?
According to Rankiteo,Ipca Laboratories Limited is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Ipca Laboratories Limited
Ipca Laboratories Limited operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at Ipca Laboratories Limited
Ipca Laboratories Limited employs approximately 13,559 people worldwide.
Subsidiaries Owned by Ipca Laboratories Limited
Ipca Laboratories Limited presently has no subsidiaries across any sectors.
Ipca Laboratories Limited’s LinkedIn Followers
Ipca Laboratories Limited’s official LinkedIn profile has approximately 401,372 followers.
NAICS Classification of Ipca Laboratories Limited
Ipca Laboratories Limited is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Ipca Laboratories Limited’s Presence on Crunchbase
No, Ipca Laboratories Limited does not have a profile on Crunchbase.
Ipca Laboratories Limited’s Presence on LinkedIn
Yes, Ipca Laboratories Limited maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/ipca.
Cybersecurity Incidents Involving Ipca Laboratories Limited
As of January 25, 2026, Rankiteo reports that Ipca Laboratories Limited has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Ipca Laboratories Limited has an estimated 5,513 peer or competitor companies worldwide.
Ipca Laboratories Limited CyberSecurity History Information
How many cyber incidents has Ipca Laboratories Limited faced ?
Total Incidents: According to Rankiteo, Ipca Laboratories Limited has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Ipca Laboratories Limited ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
Typemill is a flat-file, Markdown-based CMS designed for informational documentation websites. A reflected Cross-Site Scripting (XSS) exists in the login error view template `login.twig` of versions 2.19.1 and below. The `username` value can be echoed back without proper contextual encoding when authentication fails. An attacker can execute script in the login page context. This issue has been fixed in version 2.19.2.
Risk Information
cvss3
Base: 5.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N
Description
A DOM-based Cross-Site Scripting (XSS) vulnerability exists in the DomainCheckerApp class within domain/script.js of Sourcecodester Domain Availability Checker v1.0. The vulnerability occurs because the application improperly handles user-supplied data in the createResultElement method by using the unsafe innerHTML property to render domain search results.
Description
A Remote Code Execution (RCE) vulnerability exists in Sourcecodester Modern Image Gallery App v1.0 within the gallery/upload.php component. The application fails to properly validate uploaded file contents. Additionally, the application preserves the user-supplied file extension during the save process. This allows an unauthenticated attacker to upload arbitrary PHP code by spoofing the MIME type as an image, leading to full system compromise.
Description
A UNIX symbolic link following issue in the jailer component in Firecracker version v1.13.1 and earlier and 1.14.0 on Linux may allow a local host user with write access to the pre-created jailer directories to overwrite arbitrary host files via a symlink attack during the initialization copy at jailer startup, if the jailer is executed with root privileges. To mitigate this issue, users should upgrade to version v1.13.2 or 1.14.1 or above.
Risk Information
cvss3
Base: 6.0
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:N/I:H/A:H
cvss4
Base: 6.0
Severity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:H/UI:N/VC:N/VI:N/VA:N/SC:N/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description
An information disclosure vulnerability exists in the /srvs/membersrv/getCashiers endpoint of the Aptsys gemscms backend platform thru 2025-05-28. This unauthenticated endpoint returns a list of cashier accounts, including names, email addresses, usernames, and passwords hashed using MD5. As MD5 is a broken cryptographic function, the hashes can be easily reversed using public tools, exposing user credentials in plaintext. This allows remote attackers to perform unauthorized logins and potentially gain access to sensitive POS operations or backend functions.
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=ipca' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
